ANXA2 and precursor B-cell acute lymphoblastic leukemia: As ANXA2 supports plasminogen activation, we hypothesized that an ANXA2-deficient BMM impairs homing, engraftment and progression of BCR-ABL1+ B-ALL via an accumulation of ECM proteins.